Summary
127.17 -0.51(-0.40%)05/10/2024
Tenet Healthcare Corp. (THC)
Tenet Healthcare Corp. (THC)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 1.38 | 10.57 | 21.74 | 40.73 | 123.15 | 78.03 | 471.22 | 527.15 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 124.07 | |
| Open | 123.20 | |
| High | 124.92 | |
| Low | 122.13 | |
| Volume | 1,231,500 | |
| Change | 1.69 | |
| Change % | 1.38 | |
| Avg Volume (20 Days) | 1,509,929 | |
| Volume/Avg Volume (20 Days) Ratio | 0.82 | |
| 52 Week Range | 51.04 - 124.92 | |
| Price vs 52 Week High | -0.68% | |
| Price vs 52 Week Low | 143.08% | |
| Range | 0.71 | |
| Gap Up/Down | 0.82 | |
Fundamentals | ||
| Market Capitalization (Mln) | 12,418 | |
| EBIDTA | 3,659,000,064 | |
| PE Ratio | 16.3205 | |
| PEG Ratio | 2.2038 | |
| WallStreet Target Price | 107.69 | |
| Book Value | 16.0880 | |
| Earnings Per Share | 5.7100 | |
| EPS Estimate Current Quarter | 0.0000 | |
| EPS Estimate Next Quarter | 0.0000 | |
| EPS Estimate Current Year | 6.0300 | |
| EPS Estimate Next Year | 7.0600 | |
| Diluted EPS (TTM) | 5.7100 | |
| Revenues | ||
| Profit Marging | 0.0297 | |
| Operating Marging (TTM) | 0.1558 | |
| Return on asset (TTM) | 0.0629 | |
| Return on equity (TTM) | 0.2592 | |
| Revenue TTM | 20,547,999,744 | |
| Revenue per share TTM | 202.1660 | |
| Quarterly Revenue Growth (YOY) | 0.0780 | |
| Quarterly Earnings Growth (YOY) | 1.4030 | |
| Gross Profit (TTM) | 7,048,000,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 16.3205 | |
| Forward PE | 15.8730 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 6.2460 | |
| Revenue Enterprise Value | 1.1591 | |
| EBITDA Enterprise Value | 7.0300 | |
| Shares | ||
| Shares Outstanding | 99,186,400 | |
| Shares Float | 90,893,455 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 1.30 | |
| Institutions (%) | 97.82 | |
05/10 10:30 EST - Zacks Investment Research
Wall Street Analysts See Tenet (THC) as a Buy: Should You Invest?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Wall Street Analysts See Tenet (THC) as a Buy: Should You Invest?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
05/10 10:01 EST - Zacks Investment Research
Is Trending Stock Tenet Healthcare Corporation (THC) a Buy Now?
Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is Trending Stock Tenet Healthcare Corporation (THC) a Buy Now?
Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
05/09 10:46 EST - Zacks Investment Research
Is Tenet Healthcare (THC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Tenet Healthcare (THC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
05/08 09:50 EST - Zacks Investment Research
Pick These 5 Lucrative GARP Stocks Using PEG Ratio
The GARP approach is for investors who are on the lookout for a mixed investment strategy. MGM, THC, ALL, RCL and EAT are some of the stocks that qualify our screening of GARP stocks.
Pick These 5 Lucrative GARP Stocks Using PEG Ratio
The GARP approach is for investors who are on the lookout for a mixed investment strategy. MGM, THC, ALL, RCL and EAT are some of the stocks that qualify our screening of GARP stocks.
05/06 14:01 EST - Zacks Investment Research
4 Sector ETFs & Stocks Likely to Benefit Despite Soft Jobs Data
The U.S. economy added 175, 000 jobs in April, well below Wall Street expectations of 240, 000.
4 Sector ETFs & Stocks Likely to Benefit Despite Soft Jobs Data
The U.S. economy added 175, 000 jobs in April, well below Wall Street expectations of 240, 000.
05/06 08:56 EST - Zacks Investment Research
5 Strong Picks to Ride the Wave of Relative Price Strength
SKYW, POWL, MTX, COCO and THC are five stocks with explosive relative price strength.
5 Strong Picks to Ride the Wave of Relative Price Strength
SKYW, POWL, MTX, COCO and THC are five stocks with explosive relative price strength.
05/03 11:01 EST - Zacks Investment Research
Best Momentum Stocks to Buy for May 3rd
NFLX, MS and THC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 3, 2023.
Best Momentum Stocks to Buy for May 3rd
NFLX, MS and THC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 3, 2023.
05/03 09:51 EST - Zacks Investment Research
Despite Fast-paced Momentum, Tenet (THC) Is Still a Bargain Stock
Tenet (THC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Despite Fast-paced Momentum, Tenet (THC) Is Still a Bargain Stock
Tenet (THC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
05/03 08:11 EST - Zacks Investment Research
New Strong Buy Stocks for May 3rd
MS, NFLX, SIGA, THC and TMHC have been added to the Zacks Rank #1 (Strong Buy) List on May 3, 2023.
New Strong Buy Stocks for May 3rd
MS, NFLX, SIGA, THC and TMHC have been added to the Zacks Rank #1 (Strong Buy) List on May 3, 2023.
05/03 05:56 EST - Zacks Investment Research
Best Value Stocks to Buy for May 3rd
SIGA, TMHC and THC made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 3, 2023.
Best Value Stocks to Buy for May 3rd
SIGA, TMHC and THC made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 3, 2023.
05/01 13:41 EST - Zacks Investment Research
Tenet Healthcare (THC) Beats on Q1 Earnings, Ups '24 EPS View
Tenet Healthcare's (THC) Q1 results reflect strength in admissions and improved pricing yield. It expects an adjusted EPS of $8.37-$9.41 for 2024, higher than the earlier mentioned $5.76-$6.90.
Tenet Healthcare (THC) Beats on Q1 Earnings, Ups '24 EPS View
Tenet Healthcare's (THC) Q1 results reflect strength in admissions and improved pricing yield. It expects an adjusted EPS of $8.37-$9.41 for 2024, higher than the earlier mentioned $5.76-$6.90.
04/30 11:31 EST - Zacks Investment Research
Tenet (THC) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Tenet (THC) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Tenet (THC) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Tenet (THC) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
04/30 09:00 EST - Zacks Investment Research
Tenet Healthcare (THC) Q1 Earnings and Revenues Top Estimates
Tenet Healthcare (THC) came out with quarterly earnings of $3.22 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.42 per share a year ago.
Tenet Healthcare (THC) Q1 Earnings and Revenues Top Estimates
Tenet Healthcare (THC) came out with quarterly earnings of $3.22 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.42 per share a year ago.
04/24 13:16 EST - Zacks Investment Research
Will Tenet (THC) Beat Estimates Again in Its Next Earnings Report?
Tenet (THC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Tenet (THC) Beat Estimates Again in Its Next Earnings Report?
Tenet (THC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
04/23 11:07 EST - Zacks Investment Research
Tenet Healthcare (THC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tenet Healthcare (THC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
04/12 14:21 EST - Schaeffers Research
Healthcare Stock Pullback Presents Opportunity for Bulls
Subscribers to Schaeffer's Weekend Trader options recommendation service received this THC commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters.
Healthcare Stock Pullback Presents Opportunity for Bulls
Subscribers to Schaeffer's Weekend Trader options recommendation service received this THC commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters.
04/05 19:21 EST - Zacks Investment Research
Tenet Healthcare (THC) Beats Stock Market Upswing: What Investors Need to Know
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $102.18, denoting a +1.46% change from the preceding trading day.
Tenet Healthcare (THC) Beats Stock Market Upswing: What Investors Need to Know
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $102.18, denoting a +1.46% change from the preceding trading day.
04/03 13:46 EST - Zacks Investment Research
Tenet Healthcare (THC) Soars 76% in a Year: What Lies Ahead?
Tenet Healthcare (THC) remains well-poised for growth on increased admissions and surgeries in the Hospital segment, acquisitions, debt repayment efforts and solid operating cash flows.
Tenet Healthcare (THC) Soars 76% in a Year: What Lies Ahead?
Tenet Healthcare (THC) remains well-poised for growth on increased admissions and surgeries in the Hospital segment, acquisitions, debt repayment efforts and solid operating cash flows.
04/03 10:36 EST - Zacks Investment Research
Should You Invest in Tenet (THC) Based on Bullish Wall Street Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Should You Invest in Tenet (THC) Based on Bullish Wall Street Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
04/02 14:01 EST - Zacks Investment Research
Tenet (THC) Divests Six Hospitals, Sustains Divestiture Spree
Tenet Healthcare (THC) completes the sale of six California hospitals, four to UCI Health and two to Adventist Health, to refine the portfolio and reduce debt burden.
Tenet (THC) Divests Six Hospitals, Sustains Divestiture Spree
Tenet Healthcare (THC) completes the sale of six California hospitals, four to UCI Health and two to Adventist Health, to refine the portfolio and reduce debt burden.